Format

Send to

Choose Destination
Value Health. 2012 May;15(3):401-3. doi: 10.1016/j.jval.2012.03.1385.

Beyond the FDA PRO guidance: steps toward integrating meaningful patient-reported outcomes into regulatory trials and US drug labels.

PMID:
22583448
DOI:
10.1016/j.jval.2012.03.1385
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center